Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mariluz Alejo as Director of Quality

Thursday, July 7th, 2022


Cubresa Appoints Mr. Matt Hudson as Chief Financial Officer and Ms. Mayra Alejo as Director of Quality

Winnipeg, MB – July 7th, 2022 – Cubresa Inc., a world leader in the design and development of PET insert systems for brain imaging, is announcing two new senior appointments: Mr. Matt Hudson as CFO and Ms. Mayra Alejo as Director of Quality.

“The addition of Matt and Mayra to the leadership team are critical as Cubresa advances into the clinical marketplace,” said James Schellenberg, Ph.D., Cubresa’s Founder and CEO. “These new appointments strengthen our team and signify the company is well positioned as we expand into new markets and regions. We are pleased to welcome them to the Cubresa family.”

Mr. Matt Hudson

Matt Hudson has over 15 years of financial and operational experience, primarily with high growth organizations. Prior to Joining Cubresa Matt was Vice President, Strategy and Transformation at People Corporation, one of the fastest growing companies in Canada. Previously he was a Senior Manager in Ernst & Young’s Assurance and Advisory practices in Canada and Australia. Matt is a CPA, CA and holds a Bachelor of Commerce (Honours) from the University of Manitoba.

Ms. Mariluz Alejo

Mariluz (Mayra) Alejo is an experienced Senior Manager with over thirty years of progressive leadership advancement in pharmaceutical, natural health products, medical devices, and food industries. She has overseen fast-paced teams covering quality, regulatory, formulation, manufacturing, validation, engineering, and project management. She has direct experience with solid and liquid dosages, biologics, active pharmaceutical ingredients, and blood banking manufacturing and food environments.

About Cubresa Inc.
Cubresa, based in Winnipeg, Canada, is a world leader in the design and development of clinical PET inserts for MRI. Cubresa products are high-performance imaging solutions designed for advanced brain imaging and are being developed to enable researchers at leading universities, hospitals, and pharmaceutical companies to visualize and measure biochemical processes at the molecular level.


Cubresa Media Contact:
Lisa Bako
VP of Sales and Strategic Partnerships
Cubresa Inc.
+1 (204) 798-4579